WFDC2 and ovarian carcinoma: The study of Xu et al (19) showed that the expression level of serum HE4 was significantly higher in a preoperative ovarian cancer group compared with healthy, benign ovarian epithelial tumor and borderline ovarian tumor groups and the differences were statistically significant (P<0.05).